cosmosjourney.com

HC allows DRL to export semaglutide, stops sales in India

Published on

Posted by

Om V Angaitkar

Categories:
MARS Matte Lip Liner | One Swipe Smooth Applicatio…
4.3 out of 5 stars(4359024)

(as of March 5, 2026 13:50 GMT +05:30 – More infoProduct prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on [relevant Amazon Site(s), as applicable] at the time of purchase will apply to the purchase of this product.)

Summary The Delhi High Court has allowed Dr Reddy’s Laboratories to produce and export its version of diabetes and anti-obesity drug Semaglutide. The decision comes amid a patent infringement case filed by Novo Nordisk.

Dr Reddy’s has been banned from selling the drug within India till March 2026. The court accepted a valid challenge to Novo Nordisk’s patent for semaglutide.